Macular edema device coming to Japan

Irvine, CA—Allergan Inc. has signed an exclusive licensing agreement with Japan's Sanwa Kagaku Kenkyusho Co. Ltd. to develop and commercialize Posurdex for the ophthalmic marketplace in that country.

Related Content:

Pharmacy

Advancement in TED treatment is a bright spot

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients